False Claims Act in Healthcare at work Florida businessman Daniel Hurt and his associated companies have recently reached a settlement agreement to pay over $27 million to the U.S. government. Hurt, who owned and operated Fountain Health Services LLC, Verify Health, Landmark Diagnostics LLC, First Choice Laboratory LLC, and Sonoran Desert Pathology Associates LLC, allegedly...
Whistleblowers play a key role in revealing fraud and corruption, risking their personal and professional lives to disclose crucial information. The following list highlights whistleblowers, not limited to False Claims Act cases, whose bravery is notable. These whistleblowers are publicly known, although anonymity is possible with proper legal support. EDWARD SNOWDEN One of the...
ERISA Lawsuit for Johnson & Johnson On February 5, 2024, a prescription drug fraud complaint was filed against Johnson & Johnson, as well as the company’s benefits committee for allegedly mismanaging its employee prescription drug benefit program. The case is a proposed class action filed in federal court by Johnson & Johnson’s Health Care Policy...
On February 8, 2023, California Attorney General Rob Bonta announced that Centene Corporation agreed to pay $215 million to settle allegations that the company and its Pharmacy Benefit Manager violated the California False Claims Act by committing prescription drug fraud against Medi-Cal. Specifically, the California Department of Justice alleged that Centene submitted false reports of...
Young Law Group, PC, announced today that it has secured a multi-million-dollar award on behalf of a whistleblower client resulting from the Securities and Exchange Commission’s $97 Million enforcement action against TIAA-CREF Individual & Institutional Services LLC, a subsidiary of Teachers Insurance and Annuity Association of America (TIAA). The SEC whistleblower case alleged that from...
Indiana PBM Fraud On March 22, 2024, the Indiana Attorney General, Todd Rokita, announced that he is filing a suit against Pharmacy Benefit Managers (PBMs) and drug manufacturers for their part in raising the price of Insulin. This drug manufacturer and PBM fraud lawsuit follows multiple actions filed by other states on the same subject...
On March 18, 2024, Delphia Inc. and Global Predictions Inc. paid $400,000 in civil penalties to settle SEC charges related to the two investment advisers misrepresenting the method by which they used artificial intelligence (AI) to support their efforts. The firms were each found to be in violation of the Advisers Act and the SEC‘s...
On March 14, 2024, the Securities and Exchange Commission (SEC) and their crypto fraud lawyer team charged 17 CryptoFX employees for allegedly carrying out a $300 million Ponzi scheme that focused on defrauding the Latino community and impacted more than 40,000 investors. These charges came after the SEC had already issued an emergency action in...
On February 28, 2024, opioid manufacturer, Endo Health Solutions Inc. (“Endo”), agreed to pay $475 million to settle U.S. v. Endo Int’l plc, Case No. 19-cv-80574, a qui tam action brought by an anonymous whistleblower, who Young Law Group represented, on behalf of the United States. The complaint alleged that the company had violated the...
On January 31, 2024, the United States Attorney’s Office of the Western District of Washington announced that Yakima Products, Inc. agreed to pay $3 million to settle allegations that the company violated the False Claims Act (FCA). Specifically, a former employee brought forth this case under the qui tam provision of the FCA alleging that...